Brazil's health insurance market is to be opened to foreign capital in order to increase competition in the sector and attempt to reduce health plan prices. According to the journal Gazeta Mercantil, medical companies are accused of boosting prices by up to 40% while inflation has risen by the relatively smaller amount of 20%, the government announced last month.
The government is aiming to provoke competition between health insurance and health plan companies, and to increase insurance market share. Last year, health insurance firms made 1.15 billion real ($1.14 billion) in premiums. The measure will also allow for more participation of foreign capital in other areas of insurance, says Marcio Coriolano, head of the private insurance superintendence, Susep.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze